Impact of TET2 mutations on response to Azacytidine in myelodysplastic syndromes and acute pauciblastic myeloid leukaemia

被引：0

作者：

Perot, Christine

机构：

来源：

HEMATOLOGIE | 2011年 / 17卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：313 / 314

页数：2

共 50 条

[41] Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
Stoelzel, Friedrich
Fordham, Sarah E.
Nandana, Devi
Lin, Wei-Yu
Blair, Helen
Elstob, Claire
Bell, Hayden L.
Mohr, Brigitte
Ruhnke, Leo
Kunadt, Desiree
Dill, Claudia
Allsop, Daniel
Piddock, Rachel
Soura, Emmanouela-Niki
Park, Catherine
Fadly, Mohd
Rahman, Thahira
Alharbi, Abrar
Wobus, Manja
Altmann, Heidi
Roellig, Christoph
Wagenfuehr, Lisa
Jones, Gail L.
Menne, Tobias
Jackson, Graham H.
Marr, Helen J.
Fitzgibbon, Jude
Onel, Kenan
Meggendorfer, Manja
Robinson, Amber
Bziuk, Zuzanna
Bowes, Emily
Heidenreich, Olaf
Haferlach, Torsten
Villar, Sara
Ariceta, Benat
Diaz, Rosa Ayala
Altschuler, Steven J.
Wu, Lani F.
Prosper, Felipe
Montesinos, Pau
Martinez-Lopez, Joaquin
Bornhaeuser, Martin
Allan, James M.
JCI INSIGHT, 2023, 8 (02)
[42] Molecular and cytogenetic abnormalities in acute myeloid leukaemia and myelodysplastic syndromes
deGreef, GE
Hagemeijer, A
BAILLIERES CLINICAL HAEMATOLOGY, 1996, 9 (01): : 1 - 18
[43] Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias
L Couronné
E Lippert
J Andrieux
O Kosmider
I Radford-Weiss
D Penther
N Dastugue
F Mugneret
M Lafage
N Gachard
N Nadal
O A Bernard
F Nguyen-Khac
Leukemia, 2010, 24 : 201 - 203
[44] TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan
Shaikh, Abdul Rehman Khalil
Ujjan, Ikram
Irfan, Muhammad
Naz, Arshi
Shamsi, Tahir
Khan, Muhammad Tariq Masood
Shakeel, Muhammad
PEERJ, 2021, 9
[45] Prognostic Impact of the Number of TET2 Mutations in Myelodysplastic and Myeloproliferative Chronic Myelomonocytic Leukemia (CMML)
Csizmar, Clifford M.
Natu, Anuya A.
Gurney, Mark
Kanagal-Shamanna, Rashmi
Loghavi, Sanam
Bazinet, Alexandre
Chien, Kelly S.
Hammond, Danielle
Lasho, Terra L.
Finke, Christy
Al-Kali, Aref
Alkhateeb, Hassan B.
Gangat, Naseema
Mangaonkar, Abhishek A.
Saliba, Antoine N.
Tefferi, Ayalew
Garcia-Manero, Guillermo
Kantarjian, Hagop
Montalban-Bravo, Guillermo
Patnaik, Mrinal M.
BLOOD, 2024, 144 : 1820 - 1821
[46] Cooperative effects of BCOR and TET2 mutations in myeloid malignancies
Schaefer, E. J.
Fares, I.
Cejas, P.
Font-Tello, A.
Meyer, C. A.
Long, H. W.
Lindsley, R. C.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 18 - 18
[47] TET2 gene harbors mutations associated with myeloid malignancies
Jankowska, A. M.
Szpurka, H.
Tiu, R. V.
Makishima, H.
Afable, M.
Huh, J.
O'Keefe, C.
Ganetzky, R.
McDevitt, M. A.
Maciejewski, J. P.
LEUKEMIA RESEARCH, 2009, 33 : S84 - S84
[48] CLINICAL IMPACT OF TET2 MUTATIONS IN ACUTE MYELOID LEUKEMIA PATIENTS HARBORING CEBPA MUTATIONS: A STUDY OF THE AML STUDY GROUP (AMLSG)
Theis, F.
Corbacioglu, A.
Gaidzik, V. I.
Paschka, P.
Weber, D.
Bullinger, L.
Schlegelberger, B.
Goehring, G.
Koehne, C. -H.
Kraemer, D.
Germing, U.
Brossart, P.
Horst, H. -A.
Haase, D.
Goetze, K.
Ringhoffer, M.
Fiedler, W.
Nachbaur, D.
Kindler, T.
Held, G.
Luebert, M.
Wattad, M.
Salih, H. R.
Krauter, J.
Heuser, M.
Thol, F.
Ganser, A.
Doehner, H.
Schlenk, R. F.
Doehner, K.
HAEMATOLOGICA, 2017, 102 : 203 - 204
[49] Prognostic role of TET2 deficiency in myelodysplastic syndromes: A meta-analysis
Lin, Yun
Lin, Zhijuan
Cheng, Kun
Fang, Zhihong
Li, Zhifeng
Luo, Yiming
Xu, Bing
ONCOTARGET, 2017, 8 (26) : 43295 - 43305
[50] Clonal Architecture Analysis of TET2 Identified Distinct Origins in Myelodysplastic Syndromes
Shi, Zhongxun
Li, Bing
Qin, Tiejun
Xu, Zefeng
Pan, Lijuan
Qu, Shiqiang
Huang, Gang
Xiao, Zhijian
BLOOD, 2020, 136

← 1 2 3 4 5 →